June 2025 Psychedelic Patent Update
The Psychedelic Patent Update provides headline figures and data regarding published psychedelic patent applications and grants.
Overview
We added 17 PCTs and 34 U.S. patent applications focused on psychedelics to our tracker in June 2025. New entries came from the likes of Soneria PBC, atai Life Sciences, 2A Biosciences, Delix Therapeutics, Compass Pathways, Xylo Bio, and more.
Using our interface, you can explore applications that were not only published or granted in these months, but also those that were allowed, abandoned, rejected, or even instances where applicants filed responses to final and non-final rejections from Examiners.
Log-in to your Pα+ account, or join today, to explore the data and continue reading.
Join Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.
- Regular Bulletins featuring news, analysis, and research
- Articles and deep dives across psychedelic drug development, policy, and research
- Exclusive interviews with researchers, executives, and policymakers
- Bespoke resources and tools including the Psychedelic Bill Tracker
- Quarterly video briefings and slide decks